Search clinical trials for: Graves Ophthalmopathy

Total 660 results

Viridian Therapeutics, Inc.

Not yet recruiting

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States
Medical University of Warsaw

Recruiting

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Thyroid Eye Disease | Ophthalmopathy | Orbitopathy, Graves

Poland
Peking University Third Hospital

Recruiting

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Thyroid Eye Disease

China
argenx

Recruiting

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease

Thyroid Eye Disease

United States
argenx

Recruiting

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

Thyroid Eye Disease

United States
Walter Reed National Military Medical Center

Recruiting

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction (Teprotumumab)

Thyroid Eye Disease | Graves Ophthalmopathy | Graves Disease

United States
Horizon Pharma USA, Inc.

Recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Thyroid Eye Disease

United States
Assiut University

Not yet recruiting

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

Thyroid Eye Disease
Lassen Therapeutics Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Eye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis

United States, United Kingdom, Spain
Viridian Therapeutics, Inc.

Recruiting

An Open-label Study for Participants Who Are Non-responders at the End of Treatment Assessment on the VRDN-001-101 and VRDN-001-301 Pivotal Studies

Thyroid Eye Disease

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease

Thyroid Eye Disease, TED

China
Sling Therapeutics, Inc.

Recruiting

A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2) (SatraGO-2)

Thyroid Eye Disease

Korea, Republic of, United States, United Kingdom, China, Canada, France, Spain
Tourmaline Bio, Inc.

Recruiting

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease (spiriTED)

Thyroid Eye Disease

United States, Jordan
Viridian Therapeutics, Inc.

Recruiting

A Randomized, Double-masked, Placebo-controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Chronic Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States, Turkey
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease

Thyroid Eye Disease | TED

Japan, Australia, United States, Argentina, Germany, Italy
ACELYRIN Inc.

Recruiting

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) (TED)

Thyroid Eye Disease

United States, Australia
Vastra Gotaland Region

Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Autoimmune Diseases | Thyroid Diseases | Mental Fatigue | Graves Ophthalmopathy | Graves Disease

Sweden
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Customized Multiple Orbital Wall Decompression for Sight-threatening Graves's Ophthalmopathy

Thyroid Eye Disease

China
First Affiliated Hospital Xi'an Jiaotong University
Nanjing First Hospital, Nanjing Medical University; Beijing Tongren Hospital; People's Hospital of Xinjiang Uygur Autonomous Region and other collaborators

Not yet recruiting

Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

Graves Ophthalmopathy

China
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Belgium, Latvia, Hungary, Spain, Slovakia, Puerto Rico, New Zealand, Turkey
Immunovant Sciences GmbH

Recruiting

Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

Thyroid Eye Disease

United States, Hungary, Spain, Latvia, Belgium
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Italy, Poland, United Kingdom, Canada, Israel, Germany, Japan
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients

Active Moderate to Severe Graves' Orbitopathy
Lassen Therapeutics 1 PTY LTD

Recruiting

A Study to Evaluate the Safety and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

Thyroid Eye Disease | Pulmonary Fibrosis

Australia, Hong Kong, New Zealand
Sling Therapeutics, Inc.

Recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Canada, Italy, United Kingdom
Medical University of Silesia

Recruiting

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Graves Orbitopathy

Poland
Viridian Therapeutics, Inc.

Recruiting

A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)

Thyroid Eye Disease

Spain, United States, Netherlands, Germany, Canada, United Kingdom, Italy, Australia, France, Turkey
National Taiwan University Hospital

Recruiting

Hydroxychloroquine in Mild Graves' Orbitopathy

Graves Ophthalmopathy

Taiwan
Sun Yat-sen University

Recruiting

Multi-model Image of Doxycycline in TAO

Thyroid Associated Ophthalmopathy

China
Sun Yat-sen University

Recruiting

Multi-model Image of Immunosuppressive Agents in TAO

Thyroid Associated Ophthalmopathy

China
University of Pisa
University of Messina; University of Catania; Università degli Studi dell'Insubria

Not yet recruiting

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study (STAGO-2)

Graves' Orbitopathy

Italy
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Imperial College London

Recruiting

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting (EHD-Pred PK)

Vasculitis | Asthma | Thyroid Eye Disease | Inflammatory Disease | COPD Exacerbation Acute

United Kingdom
Haukeland University Hospital

Recruiting

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Thyroid-Associated Ophthalmopathy

Norway
Sun Yat-sen University

Not yet recruiting

Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy

Graves Ophthalmopathy | Strabismus, Mechanical
Sun Yat-sen University

Not yet recruiting

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Thyroid Associated Ophthalmopathy

China
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Azienda Ospedaliero, Universitaria Pisana; Istituto Auxologico Italiano; Azienda... and other collaborators

Recruiting

Tocilizumab in Active Moderate-severe Graves' Orbitopathy (TOGO)

Graves Ophthalmopathy

Italy
University of Pisa

Recruiting

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy (ABLAGO)

Graves' Orbitopathy

Italy
University of Zurich

Recruiting

Exophthalmometry With 3D Face Scanners (EX3D)

Graves Ophthalmopathy | Exophthalmos | Orbital Fractures | Orbital Tumor

Switzerland
Althaia Xarxa Assistencial Universitària de Manresa
Societat Catalana d'Oftalmologia

Recruiting

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Surgical Procedure, Unspecified | Thyroid Associated Ophthalmopathy

Spain
University of Pisa

Not yet recruiting

Sirolimus for Graves' Orbitopathy (GO) (SIRGO)

Graves Ophthalmopathy

Italy
Sun Yat-sen University

Recruiting

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Thyroid Associated Ophthalmopathy

China
Sheba Medical Center

Recruiting

Tamsulosin for Thyroid Lid Retraction

Thyroid Eye Disease | Eyelid Diseases

Israel
Massachusetts Eye and Ear Infirmary
Regeneron Pharmaceuticals

Recruiting

Anti-VEGF Therapy for Acute Thyroid Eye Disease (AcTED)

Thyroid Eye Disease

United States
Johns Hopkins University

Recruiting

Bimatoprost as a Treatment for Graves' Orbitopathy

Graves Ophthalmopathy

United States
Lund University

Recruiting

Treatment of Graves´Ophthalmopathy With Simvastatin (GO-S)

Graves Ophthalmopathy | Thyroid Associated Ophthalmopathy | Thyroid Associated Orbitopathy

Sweden
University of Pisa

Not yet recruiting

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy (ORGO)

Thyroid Associated Ophthalmopathy
Sun Yat-sen University

Recruiting

Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

Immune System Diseases | Autoimmune Diseases | Endocrine System Diseases | Thyroid Diseases | Eye Diseases, Hereditary | Graves Ophthalmopathy | Graves Disease | Hyperthyroidism | Thyroid-associated Ophthalmopathy

China
Horizon Therapeutics USA, Inc.

Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Thyroid Eye Disease | Chronic (Inactive) Thyroid Eye Disease

United States

Search clinical trials for: Graves Ophthalmopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations